Experience of others

Jan Kulagowski
Drug Discovery Manager- Parkinson's UK
“ELF is a proven opportunity and asset, with many examples of how it has been successful.”
Kamil Sitarz, PhD
Director of R&D Biology, Selvita
"ELF has the experience, facilities, resources, actually all the assets needed to successfully support drug discovery programmes."
Reuven Stein, PhD & Micha Fridman, PhD
Professors, University of Tel Aviv
“ELF is one of the most fruitful channels to translate a crazy academic idea into a drug.”
Fabrice Paublant, MBA
CEO, Cellipse
“The ELF scientists were clearly focused on one thing: the success of our programme.”
Graeme Wilkinson, PhD
Consultant Pharmacologist The Research Network
“We are in a really great position to celebrate some success achieved by working with ELF”